Establishing care with a Primary Care Physician (PCP) requires a comprehensive baseline panel. Hypermobile Ehlers-Danlos Syndrome (hEDS) frequently co-occurs with Dysautonomia/POTS, Mast Cell Activation Syndrome (MCAS), and neurovascular or autoimmune overlap. Standard “annual physical” blood work often misses critical underlying issues.

This categorized guide outlines routine and specialized tests that complex care providers regularly monitor, along with the physiological rationale and clinical symptoms associated with each.

1. Organ Function & Medication Monitoring

Rationale: Many individuals with hEDS and dysautonomia rely on daily NSAIDs for pain, antihistamines or mast cell stabilizers, and high-sodium diets or fluids for POTS. Routine screening ensures these strategies do not strain the kidneys.

• Kidney Panel (BUN, Creatinine, Cystatin C):
  • Rationale: Evaluates renal filtration. Cystatin C is crucial because low muscle mass in hEDS can make standard serum creatinine look deceptively normal.
  • Associated Symptoms: Fluid retention, swollen ankles or eyelids, unexplained high blood pressure, metallic taste, nausea, or foamy urine.

• Liver Function Panel (ALT, AST, Bilirubin, Alkaline Phosphatase):
  • Rationale: Monitors hepatic health and metabolic processing of daily maintenance medications (NSAIDs, mast cell meds, autonomic agents).
  • Associated Symptoms: Right-sided upper abdominal discomfort, unexplained medication sensitivities, severe fatigue, jaundice (yellowing skin/eyes), or dark urine.

• Creatine Kinase (CK):
  • Rationale: Checks for subtle muscle tissue breakdown caused by chronic joint compensation, micro-tears from hypermobility, or severe muscle spasms.
  • Associated Symptoms: Severe localized muscle weakness, deep muscle aching, dark tea-colored urine after minor exertion, or intractable muscle cramping.

2. Expanded Micronutrients, Methylation, & Minerals

Rationale: Connective tissue breakdown, high cellular turnover, and frequent GI dysmotility can impair nutrient absorption. Key micronutrients and methylation pathways provide essential building blocks for collagen synthesis, nerve insulation, neurotransmitter production, histamine breakdown, and expanding blood volume.

Key Iron & Storage Markers

• Iron Panel & Serum Ferritin:
  • Rationale: Ferritin measures stored iron. Low ferritin (even without systemic anemia) starves tissues of oxygen delivery and impairs cardiac filling.
  • Associated Symptoms: Exacerbated POTS symptoms (tachycardia upon standing), Restless Legs Syndrome (RLS), profound fatigue, air hunger, cold intolerance, hair shedding, and exercise intolerance.

Essential Vitamins & Methylation Diagnostics

• MTHFR Genotyping (C677T & A1298C Variants):
  • Rationale: Identifies genetic variations in methylenetetrahydrofolate reductase. Reduced enzyme activity impairs the conversion of dietary folate to active L-methylfolate, affecting connective tissue repair, neurotransmitter regulation, and cellular detoxification.
  • Associated Symptoms: Poor tolerance to standard synthetic folic acid, chronic brain fog, unexplained mood fluctuations/anxiety, slow tissue healing/bruising, and poor medication clearance.

• Homocysteine (Plasma):
  • Rationale: A key functional biomarker for methylation efficiency. Impaired MTHFR activity or low B₁₂/folate can cause homocysteine accumulation, which irritates the microvascular lining and increases systemic inflammation.
  • Associated Symptoms: Recurrent migraines/headaches, microvascular pain, cold extremities, cognitive dysfunction, and unexplained cardiovascular strain.

• Vitamin D₃ (25-Hydroxyvitamin D):
  • Rationale: Crucial for bone density, immune regulation, and collagen turnover.
  • Associated Symptoms: Deep bone pain, frequent joint subluxations/instability, muscle weakness, slow wound healing, and heightened systemic autoimmune flares.

• Vitamin B₁₂ & Serum Folate:
  • Rationale: Vital for myelin sheath integrity (nerve insulation), red blood cell synthesis, and peripheral neuropathy screening.
  • Associated Symptoms: Numbness/tingling in hands or feet (paresthesia), burning nerve pain, balance issues, “brain fog”, smooth/sore tongue, and severe fatigue.

• Methylmalonic Acid (MMA):
  • Rationale: Provides a sensitive, tissue-level measure of functional B₁₂ deficiency (even if standard serum B₁₂ appears normal).
  • Associated Symptoms: Subclinical neurological issues, subtle gait unsteadiness, sensory loss in extremities, and unexplained cognitive decline.

• Vitamin B₆ (Pyridoxal-5-Phosphate / P5P):
  • Rationale: Important for nerve health and neurotransmitter production. Note: Monitor both deficiency and toxicity, as excess B₆ can induce small fiber neuropathy.
  • Associated Symptoms: Deficiency: Cracked mouth corners, mood changes, seizures. Toxicity: Sudden-onset stocking-glove numbness, severe nerve burning, or electric-shock sensations in limbs.

• Vitamin B₁ (Thiamine):
  • Rationale: Critical for autonomic nervous system function, cardiac muscle contractility, and cellular energy metabolism.
  • Associated Symptoms: Gastroparesis (severe post-meal fullness, early satiety), orthostatic intolerance, extreme muscular exhaustion, calf weakness, and dysautonomic digestive failure.

Critical Minerals & Co-Factors

• RBC Magnesium:
  • Rationale: Red Blood Cell (RBC) magnesium measures intracellular levels that directly govern vascular and muscle tone, far superior to standard serum magnesium.
  • Associated Symptoms: Intractable muscle spasms/fasciculations, heart palpitations/arrhythmias, insomnia, heightened anxiety, and vasospasms (Raynaud’s-like cold digits).

• Copper & Zinc Balance:
  • Rationale: Copper is a mandatory co-factor for lysyl oxidase (the enzyme that cross-links collagen) and diamine oxidase (DAO, the enzyme that degrades extracellular histamine). Zinc must be balanced alongside it.
  • Associated Symptoms: Low Copper: Fragile blood vessels, easy bruising, high histamine sensitivity. Imbalance: Poor wound healing, loss of taste/smell, joint laxity, skin rashes, and histamine intolerance.

• Selenium:
  • Rationale: Essential for thyroid hormone conversion (T₄ to T₃) and reducing oxidative stress in connective tissue.
  • Associated Symptoms: Cold intolerance, unexplained hair thinning, muscle weakness, and thyroid dysfunction despite normal TSH.

3: Autonomic, Endocrine, & Pituitary-Pressure Axis Screening

Rationale: Autonomic dysfunction disrupts fluid retention and vascular tone. Mechanical stalk strain or gland compression from high ICP (Empty Sella Syndrome) or Low ICP (Pituitary Engorgement/Swelling from CSF leaks), alongside primary endocrine imbalances, can masquerade as or severely exacerbate dysautonomic flares.

• Serum & Urine Osmolality + Sodium (Posterior Pituitary / ADH Axis):
  • Rationale: Evaluates Antidiuretic Hormone (ADH/Vasopressin) signaling. High ICP compression or CSF leak traction on the posterior pituitary stalk disrupts ADH secretion, driving central diabetes insipidus (DI) or SIADH.
  • Associated Symptoms: Unquenchable thirst (polydipsia), massive production of clear urine (>3L/day), rapid dehydration despite heavy salt/water loading, sudden drops in blood sodium, and severe standing dizziness.

• Morning Cortisol & ACTH (8:00 AM Draw):
  • Rationale: Evaluates the hypothalamic-pituitary-adrenal (HPA) axis to screen for central adrenal insufficiency caused by pituitary flattening or stalk strain.
  • Associated Symptoms: Inability to handle stress, severe low blood pressure crashes (<90/60 mmHg), profound morning exhaustion, hypoglycemia, and dizziness.

• Prolactin (Pituitary Stalk Integrity):
  • Rationale: Checks for “stalk effect” hyperprolactinemia. Physical stretching or compression of the pituitary stalk by an empty sella or swollen gland stops dopamine from inhibiting prolactin.
  • Associated Symptoms: Unexplained galactorrhea (breast secretion), menstrual irregularities/amenorrhea, low libido, chronic base-of-skull or retro-orbital headaches.

• IGF-1 (Insulin-like Growth Factor 1 / Growth Hormone Axis):
  • Rationale: Growth Hormone is often the first pituitary hormone lost when the gland is flattened in Empty Sella Syndrome. IGF-1 measures the functional GH output needed for collagen repair and muscle maintenance.
  • Associated Symptoms: Profound exhaustion, severe muscle recovery failure after light effort, loss of lean tissue mass, cold sensitivity, and thin/fragile skin.

• Full Thyroid Panel (TSH, Free T₃, Free T₄, Thyroid Antibodies – TPO/TgAb):
  • Rationale: Differentiates primary autoimmune thyroid disease (Hashimoto’s) from central hypothyroidism (low or “normal” TSH with low Free T₄ caused by pituitary failure).
  • Associated Symptoms: Temperature dysregulation, unexplained weight changes, brain fog, dry skin, constipation, or tachycardia.

• Sex Hormone Panel (Estradiol, Progesterone, LH, FSH, Total/Free Testosterone, DHEA-S):
  • Rationale: Evaluates the gonadal axis (susceptible to pituitary compression) and tracks sex steroids that alter vascular tone, joint laxity (estrogen increases hypermobility), and mast cell stability (progesterone stabilizes mast cells).
  • Associated Symptoms: Severe symptom flares during specific menstrual cycle phases, joint subluxations prior to menses, loss of muscle tone, and menstrual irregularities.

• Electrolytes (Sodium, Potassium, Chloride, Bicarbonate):
  • Rationale: Tracks baseline fluid retention and kidney balance, essential for monitoring high-salt diets, volume expanders (fludrocortisone), or diuretics used for high ICP (acetazolamide/topiramate).
  • Associated Symptoms: Dizziness on standing, muscle cramping/weakness, heart palpitations, and confusion.

4. Standard Systemic Inflammatory Markers

Rationale: Broad first-line screens used to detect acute-phase proteins produced by the liver during general systemic stress.

• hs-CRP (High-Sensitivity C-Reactive Protein):
  • Rationale: Detects subtle, low-grade vascular and systemic inflammation that standard CRP tests miss.
  • Associated Symptoms: Low-grade feverish sensations, generalized vascular aching, flu-like feeling without infection, and throbbing joint pain.

• ESR (Erythrocyte Sedimentation Rate / “Sed Rate”):
  • Rationale: Measures how rapidly red blood cells settle, indicating general systemic inflammatory changes.
  • Associated Symptoms: Widespread body aches, morning joint stiffness lasting >1 hour, muscle soreness, and systemic fatigue.

5. Autoimmune & Rheumatic Panels (Including AS & Sjögren’s)

Rationale: Co-occurring autoimmune conditions—such as Ankylosing Spondylitis (AS), Sjögren’s Syndrome, Lupus, or Rheumatoid Arthritis—frequently overlap with hEDS, driving axial spinal inflammation, small fiber neuropathy, and systemic flares.

• HLA-B27 Genetic Marker (Ankylosing Spondylitis / SpA Screen):
  • Rationale: Key genetic marker for axial spondyloarthritis. Differentiates inflammatory spinal/SI joint pathology from mechanical hEDS instability.
  • Associated Symptoms: Inflammatory lower back/buttock pain (worse with rest, improves with movement), waking up with spinal stiffness in the 2nd half of the night, rib/chest wall pain (costochondritis), and tendon insertion pain (Achilles tendonitis/plantar fasciitis).

• ANA (Antinuclear Antibodies) with Reflex Titer/Pattern:
  • Rationale: Initial screening for systemic autoimmune activity (Lupus, Scleroderma, Mixed Connective Tissue Disease).
  • Associated Symptoms: Malar (butterfly) facial rash, photosensitivity, unexplained recurring fevers, multi-joint swelling.

• ENA Panel — SSA/Ro (Ro52/Ro60) & SSB/La (Sjögren’s Antibodies):
  • Rationale: Crucial for identifying Sjögren’s Syndrome, which commonly drives autonomic failure and small fiber neuropathy in hEDS.
  • Associated Symptoms: Severe dry eyes (“sand/grit” in eyes), dry mouth/difficulty swallowing dry food, painful salivary gland swelling, burning neuropathic body pain.

• Early Sjögren’s Biomarker Panel (CA VI, PSP, LAP) & Lip Biopsy (if SSA/SSB negative):
  • Rationale: Screens for seronegative or early-stage Sjögren’s when standard blood panels are normal but autonomic/neuropathic symptoms are present.
  • Associated Symptoms: Dysautonomia flares, early small fiber neuropathy, dry mucous membranes.

• Rheumatoid Factor (RF) & Anti-CCP:
  • Rationale: Differentiates autoimmune synovial joint inflammation from hEDS mechanical joint instability.
  • Associated Symptoms: Symmetrical joint swelling (especially knuckles/wrists), joint warmth/redness, and morning joint locking.

• Complement System (C₃ & C₄):
  • Rationale: Low levels indicate active complement consumption during autoimmune flares.
  • Associated Symptoms: Sudden systemic disease flares, vasculitis rashes (purple dots on skin), or lupus-like organ symptoms.

6. How to Test for Mast Cell Activation Syndrome (MCAS)

Rationale: Standard inflammatory markers (like CRP and ESR) are frequently completely normal during severe MCAS flares because mast cells release localized chemical mediators rather than traditional liver-derived proteins. Standard diagnostic criteria rely on comparing baseline and flare states.

The Core Tryptase Diagnostic Formula

Under official diagnostic consensus guidelines (Consensus-1 / International Criteria), confirming MCAS via blood work requires showing a transient, significant rise in serum tryptase during an acute episode compared to your healthy baseline:

Diagnostic Threshold = (1.20 x Baseline Serum Tryptase) + 2ng/mL

Step 1: Baseline Serum Tryptase (sBT)

• When to draw: Drawn during a “quiescent” period—when feeling relatively stable and not experiencing an acute flare.

• What it tells you: Establishes resting mast cell burden. A single elevated baseline tryptase (> 11.4ng/mL) screens for Hereditary Alpha-Tryptasemia (HαT) or mastocytosis.

Step 2: Acute “Flare” Tryptase

• When to draw: Drawn within the 1 to 4 hour window following the start of an acute, severe symptom flare.

• Interpretation: If flare tryptase exceeds the formula threshold relative to baseline, it satisfies the official lab criteria for acute mast cell activation.

Secondary Mast Cell Mediators (Urine & Plasma)

Because tryptase clears quickly or may remain normal in some MCAS variants, experts order additional mediators to capture off-peak activation:

• Prostaglandin D₂ (PGD₂) & 11-Beta Prostaglandin F2α:
  • Associated Symptoms: Profuse episodic skin flushing, sudden “hot flashes”, deep bone/joint pain, severe brain fog, and uterine/GI cramping.

• Urine N-Methylhistamine & Plasma Histamine:
  • Associated Symptoms: Sudden hives (urticaria), itching (pruritus), nasal congestion, rapid heart rate (tachycardia), and low blood pressure/dizziness.

• Leukotriene E₄ (LTE₄):
  • Associated Symptoms: Shortness of breath, wheezing, throat tightness, microvascular swelling (angioedema in lips/face/hands), and sudden loose stools.

Genetic & Differential Screening

• Genetic Test for Hereditary Alpha-Tryptasemia (HαT):
  • Rationale: A digital droplet PCR swab or blood test checking for extra copies of the $TPSAB1$ gene. Present in 5–6% of the general population (and higher in hEDS/POTS cohorts).
  • Associated Symptoms: High baseline tryptase, lifelong vibration/heat sensitivity, joint hypermobility, flushing, and irritable bowel symptoms.

• Peripheral Blood KIT D816V Mutation:
  • Rationale: Rules out systemic mastocytosis (clonal mast cell disease).
  • Associated Symptoms: Fixed reddish-brown skin spots (urticaria pigmentosa), unexplained bone fractures/osteoporosis, and enlarged spleen or liver.

⚠️ Strict Cold-Chain Handling Mandatory: Mast cell mediators degrade rapidly at room temperature. Urine containers and plasma samples must be kept strictly chilled/chilled-on-ice throughout collection, storage, and lab transport. Room-temperature exposure is the #1 cause of false-negative MCAS results.

7. Neuro-Inflammatory & Microvascular Screening

Rationale: Connective tissue laxity and high pressure can compromise the blood-brain barrier and peripheral nerves, driving neurovascular inflammation.

• Quantitative Immunoglobulins (IgG, IgA, IgM, IgE) & IgG Subclasses:
  • Rationale: Evaluates overall immune competence and screens for subtle immunodeficiencies or chronic neuro-inflammatory states.
  • Associated Symptoms: Recurrent sinus or chest infections, chronic lingering illness, severe environmental allergies (high IgE), or neurological sensitivity.

• Antiphospholipid Antibodies (Cardiolipin, Beta-2 Glycoprotein, Lupus Anticoagulant):
  • Rationale: Evaluates hypercoagulable or microvascular inflammatory states that can impair tissue perfusion and drive chronic headaches.
  • Associated Symptoms: Livedo reticularis (mottled, net-like blue/purple skin pattern); persistent base-of-skull headaches; cold, painful fingers/toes; or history of unexplained blood clots/miscarriages.

How to Introduce This to Your PCP

When introducing this list to a primary care physician (PCP), frame it as a proactive baseline strategy:

“Because my condition involves multi-system strain, hypermobility, and autonomic dysfunction, my care relies heavily on regular medication, hydration, and nutritional management. I want to establish a solid baseline panel that we can re-check periodically to monitor my organ safety, micronutrients, electrolytes, and inflammatory markers. This gives us a clear benchmark to compare against whenever I experience a major flare.“

Strategy for Working with Non-Specialist PCPs

If your provider is not an hEDS, dysautonomia, or MCAS specialist, handing them a full 30+ item lab list all at once can sometimes feel overwhelming or lead to pushback. To collaborate effectively with your PCP:

1. Review Associated Symptoms: Look through the Associated Symptoms bullet points under each category before your visit.
2. Prioritize Relevant Labs: Highlight only the specific tests that align directly with the symptoms or flares you are actively experiencing.
3. Phase the Testing: Start with foundational categories (Organ Function, Basic Micronutrients, Thyroid, and Standard Inflammatory Markers) for your initial baseline. You can then request niche tests (such as full MCAS mediators or specialist autoimmune panels) if initial screens show abnormalities or during severe flares.